Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0J8JF
|
|||
Former ID |
DIB014123
|
|||
Drug Name |
RG-4934
|
|||
Synonyms |
IL-17 huMAb (psoriatic arthritis), Roche
Click to Show/Hide
|
|||
Drug Type |
Antibody
|
|||
Indication | Arthritis [ICD-11: FA20] | Discontinued in Phase 1 | [1] | |
Company |
Roche Holding AG
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Interleukin-17 (IL17) | Target Info | . | [2] |
KEGG Pathway | Cytokine-cytokine receptor interaction | |||
Inflammatory bowel disease (IBD) | ||||
Rheumatoid arthritis | ||||
NetPath Pathway | TCR Signaling Pathway | |||
Panther Pathway | Interleukin signaling pathway | |||
Pathway Interaction Database | IL27-mediated signaling events | |||
IL23-mediated signaling events | ||||
WikiPathways | TCR Signaling Pathway | |||
Allograft Rejection | ||||
IL17 signaling pathway |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800032677) | |||
REF 2 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800032677) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.